Copper Deficiency Treatment in Patients with History of Bariatric Bypass Surgery

Bariatric bypass surgery significantly alters micronutrient absorption, placing patients at ongoing risk for copper deficiency. When serum copper falls into the moderate deficiency range, a structured, guideline-supported intervention is indicated.

Clinical Scenario

History of bariatric bypass surgery with confirmed moderate copper deficiency — serum copper values in the range of 8–12 μmol/L (0.5–0.8 mg/dL). Both the ASMBS and BOMSS guidelines specifically address this level of deficiency in post-bariatric patients.

Treatment Approach

Oral copper supplementation is the primary intervention for this scenario. The structured protocol specifies the agent, dosing regimen, and endpoint — see the full regimen for complete details…

Clinical Goals

The treatment target is normalization of serum copper levels or resolution of clinical symptoms. With appropriate management, hematologic manifestations are expected to normalize within 12 weeks.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1002/ncp.10328

For moderate deficiency (ie, values 8–12 μmol/L, 0.5–0.8 mg/dL), the American Society for Metabolic and Bariatric Surgery Clinical Practice (ASMBS) guidelines and the British Obesity and Metabolic Surgery Society (BOMSS) recommend the administration of 3–8 mg/d of copper sulfate or gluconate until level normalization or symptom resolution.

With proper treatment, hematologic manifestations should normalize by 12 weeks, whereas evolution of neurologic symptoms is unclear.

View source ↗